Back to search results

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge

Abroad (travel likely)RecruitingPHASE3

Conditions

Penicillin Allergy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Texas Tech University Health Sciences Center, Lubbock, Texas, United States

    Study coordinator · clinicalresearch@ttuhsc.edu · 806-543-8994
    Contact: Study coordinator (Joshua A Peterson, MD) · josh.peterson.587@gmail.com
    Joshua A Peterson, MD (Sub-investigator)
    Nicole Welch, MD (Sub-investigator)
    KaKa L Adams, MD (Sub-investigator)
    Sierra Sullivan, MD (Sub-investigator)
    Contact: Principal Investigator (Jacob Nichols, MD)
    Contact: Principal Investigator (James A Tarbox, MD)
    Watsachon Pangkanon, MD (Sub-investigator)
    Nattanicha Chaisrimaneepan, MD (Sub-investigator)
    Safa Mohamed, MD (Sub-investigator)
    Maireigh McCullough, MD (Sub-investigator)
    Diego Olavarria Bernal, MD (Sub-investigator)
    Miriam Paz Sierra, MD (Sub-investigator)
Study leads

  • James A Tarbox, MD

    Principal Investigator

    Texas Tech University Health Sciences Center

View source on ClinicalTrials.gov(opens in a new tab)